Is the Physiological Composition of the Vaginal Microbiome Altered in High-Risk HPV Infection of the Uterine Cervix?

Viruses. 2022 Sep 27;14(10):2130. doi: 10.3390/v14102130.

Abstract

Background: Cervical cancer is the fourth most common malignancy and fourth leading cause of cancer death in women worldwide. More than 99.7% of cases are caused by human papillomavirus (HPV), while HPV types 16 and 18 cause over 70% of all cervical cancer cases. In this preliminary study, we aimed to investigate the presence of HPV infection and diversity of bacteria associated with bacterial vaginosis.

Methods: Cervical swabs (n = 21) taken from women aged 21-47 years, in seventeen cases, with different degrees of cervical abnormality, and from four healthy women, were tested for the presence of HPV DNA, as well as the bacterial strains associated with bacterial vaginosis, using the real-time PCR method.

Results: HPV16 was the dominant genotype in 53% (9/17) of patients with confirmed precancerous lesions (ASCUS, LSIL, and HSIL). In specimens with confirmed cytological abnormalities and hrHPV infection, we detected a wide diversity of microbes, while the most common species were Gardnerella vaginalis, Atopobium vaginae, Prevotella bivia, Ureaplasma parvum, Ureaplasma urealyticum, Leptotrichia amnionii, Bacteroides ureolyticus, and Sneathia sanguinegens. The presence of pathogens did not differ, depending on the degree of precancerous lesions or HPV type.

Conclusion: In our work, HPV16 dominated in patients with cervical precancerous lesions. We also suggest an increased bacterial diversity of the vaginal microbiome in patients with cervical lesions, for which the HPV virus is largely responsible.

Keywords: HPV; cervical precancerosis; human viruses; vaginal microbiome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cervix Uteri
  • Female
  • Human papillomavirus 16 / genetics
  • Humans
  • Microbiota*
  • Papillomaviridae / genetics
  • Papillomavirus Infections* / complications
  • Precancerous Conditions* / microbiology
  • Uterine Cervical Neoplasms*
  • Vaginosis, Bacterial* / microbiology

Grants and funding

This research was funded by project VEGA 1/0398/21, Immune system and vaginal microbiome as important mediator in the process of cervical carcinogenesis, and co-financed by the Ministry of Education, Science, Research, and Sport of the Slovak Republic, as well as by project Lisper, ITMS 313011V446: Integrative strategy in the development of personalized medicine of selected malignant tumors and its impact on quality of life. Operational program integrated infrastructure 2014–2020.